Inventor · disambiguated record
Ellalahewage Sathyajith Kumarasinghe
Also filed as: KUMARASINGHE ELLALAHEWAGE · KUMARASINGHE ELLALAHEWAGE S · KUMARASINGHE ELLALAHEWAGE SATHYAJITH
41 granted patents·14 pending applications·288 citations·filing 2003–2023
98Inventor score
Files withMODERNATX INC48BAYER PHARMACEUTICALS CORP2BAYER HEALTHCARE AG1BOYER STEPHEN1MAGNUSON STEVEN1
Top patents by PatentIndex Score
55 records- 0198US11497807B2Zoonotic disease RNA vaccinesMODERNATX INC·Filed 2021·Granted Nov 15, 2022·36 cites·20 claims
- 0298US11344504B1Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2021·Granted May 31, 2022·4 cites·29 claims
- 0398US10285950B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted May 14, 2019·13 cites·20 claims
- 0498US10172808B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jan 8, 2019·19 cites·18 claims
- 0597US12151995B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2023·Granted Nov 26, 2024·4 cites·30 claims
- 0697US11071716B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2020·Granted Jul 27, 2021·3 cites·20 claims
- 0797US10857105B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2019·Granted Dec 8, 2020·82 cites·30 claims
- 0897US10646549B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2018·Granted May 12, 2020·13 cites·20 claims
- 0996US11000573B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2020·Granted May 11, 2021·3 cites·20 claims
- 1096US10406113B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·30 claims
- 1195US11596609B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Mar 7, 2023·1 cites·20 claims
- 1295US11504337B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2019·Granted Nov 22, 2022·12 cites·19 claims
- 1395US10322090B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1495US10322091B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1594US11597698B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2021·Granted Mar 7, 2023·15 cites·24 claims
- 1694US11066355B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2020·Granted Jul 20, 2021·23 cites·30 claims
- 1792US10973917B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2019·Granted Apr 13, 2021·4 cites·27 claims
- 1892US10335486B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2018·Granted Jul 2, 2019·8 cites·23 claims
- 1991US11001861B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2017·Granted May 11, 2021·11 cites·50 claims
- 2091US10494636B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 3, 2019·3 cites·8 claims
- 2190US11311602B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2021·Granted Apr 26, 2022·1 cites·31 claims
- 2289US11185510B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2019·Granted Nov 30, 2021·1 cites·26 claims
- 2388US10730924B2Polynucleotides encoding relaxinMODERNATX INC·Filed 2018·Granted Aug 4, 2020·5 cites·21 claims
- 2487US12324859B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2020·Granted Jun 10, 2025·1 cites·11 claims
- 2584US11649461B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2019·Granted May 16, 2023·1 cites·21 claims
- 2684US10993918B2Polynucleotides encoding citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2017·Granted May 4, 2021·2 cites·50 claims
- 2783US2023041964A1Combinations of mrnas encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2882US11801227B2Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNATX INC·Filed 2017·Granted Oct 31, 2023·1 cites·30 claims
- 2982US11571463B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2022·Granted Feb 7, 2023·0 cites·23 claims
- 3082US2024024422A1Polynucleotides encoding interleukin-12 (il12) and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 3182US2023323371A1Polynucleotides encoding alpha-galactosidase a for the treatment of fabry diseaseMODERNATX INC·Filed 2023·Application pending·0 cites
- 3282US2023270685A1POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASEMODERNATX INC·Filed 2022·Application pending·0 cites
- 3381US2023346928A1Mrna combination therapy for the treatment of cancerMODERNATX INC·Filed 2023·Application pending·0 cites
- 3479US12312293B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 3578US10519455B2Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 31, 2019·1 cites·29 claims
- 3677US2024318187A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 3776US11660341B2mRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2021·Granted May 30, 2023·0 cites·31 claims
- 3875US12377136B2Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2022·Granted Aug 5, 2025·0 cites·11 claims
- 3975US8349865B2Inhibitors of janus kinasesMERCK SHARP & DOHME·Filed 2008·Granted Jan 8, 2013·3 cites·7 claims
- 4075US2023270836A1Zoonotic disease rna vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 4172US2024238210A1Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNA TX INC·Filed 2023·Application pending·0 cites
- 4269US12252704B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 4368US12239742B2Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2021·Granted Mar 4, 2025·0 cites·3 claims
- 4465US12103955B2Polynucleotides encoding relaxinMODERNATX INC·Filed 2020·Granted Oct 1, 2024·0 cites·27 claims
- 4565US8796253B2Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBOYER STEPHEN·Filed 2008·Granted Aug 5, 2014·1 cites·20 claims
- 4663US2020030432A1Zoonotic disease rna vaccinesMODERNATX INC·Filed 2018·Application pending·0 cites
- 4754US2020085916A1Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2017·Application pending·0 cites
- 4853US2019382774A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 4949US12128113B2Polynucleotides encoding JAGGED1 for the treatment of Alagille syndromeMODERNATX INC·Filed 2017·Granted Oct 29, 2024·0 cites·32 claims
- 5046US8338594B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2006·Granted Dec 25, 2012·0 cites·14 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ellalahewage Sathyajith Kumarasinghe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →